Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description Turner & Townsend is a global professional services company with over 22,000 people in more than 60 countries. Working with our clients across real estate, infrastructure, energy and natural resources, we transform together delivering
Idorsia Ltd is reaching out for more – We have more ideas, we see more opportunities and we want to help more patients. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical
Idorsia Ltd is reaching out for more – We have more ideas, we see more opportunities and we want to help more patients. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical
THE OPPORTUNITY Are you an AI-native software engineer ready to shape how enterprise brands appear in AI? The Adobe Brand Visibility team builds the systems that determine how enterprise brands appear in ChatGPT, Gemini, and the
THE OPPORTUNITY Are you an AI-native software engineer ready to help enterprises stay visible in the era of AI? The Adobe Brand Visibility team builds the systems that determine how enterprise brands appear in ChatGPT, Gemini,
THE OPPORTUNITY The way brands are discovered online is changing as search engines, AI assistants, and large language models increasingly shape how users find information and interact with content. Adobe’s Domain Experts team operates where SEO,
About the role Adobe Experience Manager is being reinvented around AI. Agentic systems now migrate legacy sites, redesign them to brand, generate new experiences from a brief, and stand them up on modern edge delivery. Most of
THE OPPORTUNITY Are you an AI-native engineer who wants to own the full build–measure–learn loop for a product at the frontier of AI discovery? The Adobe Brand Visibility team builds the systems that determine how enterprise
THE OPPORTUNITY Adobe is looking for a leader to analyze, structure, and continuously improve our Product-Led Growth (PLG) workstreams — aligning them with Adobes operating model while protecting the speed, autonomy, and data-driven decision culture that
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
THE OPPORTUNITY AEM Assets is Adobes digital asset management platform - a Gartner-ranked Leader in Digital Asset Management for over a decade, with agentic AI already shipped and in production: Content Advisor for conversational search, Governance
THE OPPORTUNITY AEM Assets is Adobes digital asset management platform - a Gartner-ranked Leader in Digital Asset Management for over a decade, with agentic AI already shipped and in production: Content Advisor for conversational search, Governance
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description Turner & Townsend is a global professional services company with over 22,000 people in more than 60 countries. Working with our clients across real estate, infrastructure, energy and natural resources, we transform together delivering
Viking (NYSE: VIK) is a global leader in experiential travel with a fleet of more than 100 ships, exploring 21 rivers, five oceans and all seven continents. Designed for curious travelers with interests in science, history,
Deine Mission Du bist kommunikativ, schreibst leidenschaftlich gerne und behältst auch in einem sehr dynamischen Umfeld den Überblick? Du möchtest den FC Basel 1893 medial mitgestalten und dabei unterstützen, den gesamten Club kommunikativ bestmöglich vorwärtszubringen? Dann
Pierre Fabre Laboratories sucht eine engagierte Marketing-Fachkraft, die das Team im B2B2C und B2C Umfeld unterstützt. Sie arbeiten eng mit Brand Activation Managern zusammen, um Omnichannel-Marketingpläne operativ umzusetzen. Zu Ihren Aufgaben gehören Content Management, Kampagnenkoordination, Website- und